137 related articles for article (PubMed ID: 6289384)
1. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
Lenz HJ; Fisher LA; Vale WW; Brown MR
Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
[TBL] [Abstract][Full Text] [Related]
3. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
MacCannell KL; Lederis K; Hamilton PL; Rivier J
Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
Rivier C; Rivier J; Lederis K; Vale W
Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
[TBL] [Abstract][Full Text] [Related]
5. Sauvagine: effects on thermoregulation in the rat.
Broccardo M
Pharmacol Res; 1990; 22(2):189-96. PubMed ID: 2330343
[TBL] [Abstract][Full Text] [Related]
6. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
Fryer J; Lederis K; Rivier J
Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro comparisons of biological activities of bovine, ovine and rat CRF (corticotrophin-releasing factor).
Yasuda N; Yasuda Y; Aizawa T; Maruta S; Greer MA
Acta Endocrinol (Copenh); 1984 Jun; 106(2):158-67. PubMed ID: 6328821
[TBL] [Abstract][Full Text] [Related]
8. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
Brown MR; Hauger R; Fisher LA
Brain Res; 1988 Feb; 441(1-2):33-40. PubMed ID: 2834002
[TBL] [Abstract][Full Text] [Related]
9. The effect of intracerebroventricular infusions of CRF, sauvagine, ACTH (1-24) and ACTH (4-10) on blood pressure in sheep.
Scoggins BA; Coghlan JP; Denton DA; Nelson MA; Lambert PF; Parkes DG; Tregear GW; Tresham JJ; Wang XM
J Hypertens Suppl; 1984 Dec; 2(3):S67-8. PubMed ID: 6100757
[TBL] [Abstract][Full Text] [Related]
10. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats.
Broccardo M; Improta G
Eur J Pharmacol; 1990 Jul; 182(2):357-62. PubMed ID: 2397746
[TBL] [Abstract][Full Text] [Related]
11. Sauvagine induces release of adrenocorticotropin, beta-endorphin and corticosterone in rats.
Negri L; Melchiorri P; Montecucchi PC; Henschen A; D'Urso R; Iellamo R; Falaschi P
Pharmacol Res Commun; 1983 Apr; 15(4):427-38. PubMed ID: 6306700
[TBL] [Abstract][Full Text] [Related]
12. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
Yasuda Y; Yasuda N
Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
[TBL] [Abstract][Full Text] [Related]
13. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
Fryer J; Lederis K; Rivier J
Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the behavioral effects of CRF, sauvagine and urotensin I.
Britton DR; Hoffman DK; Lederis K; Rivier J
Brain Res; 1984 Jun; 304(2):201-5. PubMed ID: 6611193
[TBL] [Abstract][Full Text] [Related]
15. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
Rivier C; Vale W
Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake.
Gosnell BA; Morley JE; Levine AS
Pharmacol Biochem Behav; 1983 Nov; 19(5):771-5. PubMed ID: 6359178
[TBL] [Abstract][Full Text] [Related]
17. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro.
Tonon MC; Cuet P; Lamacz M; Jégou S; Côté J; Gouteaux L; Ling N; Pelletier G; Vaudry H
Gen Comp Endocrinol; 1986 Mar; 61(3):438-45. PubMed ID: 3007273
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function.
Brown MR; Gray TS; Fisher LA
Regul Pept; 1986 Dec; 16(3-4):321-9. PubMed ID: 3031745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
